Paratek Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Paratek Pharmaceuticals

09/08/2021 22:01

* Paratek Pharmaceuticals Inc  PRTK.OQ  reported quarterly
adjusted earnings of 20 cents​​ per share for the quarter ended
in June. The mean expectation of five analysts for the quarter
was for earnings of 32 cents per share.
* Revenue fell 94.8% to $489.00 thousand from a year ago; 
analysts expected $60.99 million. 
* The mean earnings estimate of analysts had risen by
about 337.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Paratek Pharmaceuticals Inc shares had fallen by 15.2% this
quarter and lost 7.7% so far this year.
* Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $15.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated